Valeant Pharmaceuticals (VRX) volatility stays elevated after less than expected Q3 and outlook

Valeant Pharma (NYSE: VRX) November weekly call option implied volatility is at 142, November is at 116, December is at 95; compared to its 52-week range of 53 to 173 after reporting less than expected Q3 results and outlook

You May Also Be Interested In

• Bentley Systems Inc. (BSY) 10400 contracts of July 35 calls trade, share price up 6%
• Sandisk (SNDK) call put ratio 1.2 calls to 1 put as share price down 10.5%
• Micron Technology (MU) call put ratio 1.1 calls to 1 put with a focus on July 520 puts